La Jolla Pharmaceutical Company (NASDAQ:LJPC) traded up 16.31% on Tuesday, hitting $12.62. The stock had a trading volume of 1,418,101 shares. La Jolla Pharmaceutical Company has a 52 week low of $0.16 and a 52 week high of $19.50. The stock has a 50-day moving average of $8.66 and a 200-day moving average of $9.13. The company’s market cap is $99.3 million.
La Jolla Pharmaceutical Company (NASDAQ:LJPC) last announced its earnings results on Friday, May 2nd. The company reported ($0.93) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.91) by $0.02. Analysts expect that La Jolla Pharmaceutical Company will post $-3.30 EPS for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Noble Financial raised their price target on shares of La Jolla Pharmaceutical Company from $34.00 to $38.00 in a research note on Wednesday, July 9th. They now have a “buy” rating on the stock. Separately, analysts at Zacks downgraded shares of La Jolla Pharmaceutical Company to a “neutral” rating in a research note on Wednesday, May 7th. They now have a $9.70 price target on the stock. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $27.14.
La Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the development of therapeutic agents that inhibit the activity of galectins as a means of treating human diseases such as chronic organ failure and cancer.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.